Transcode Therapeutics reported net income of -$6.87M for the quarter ended Jun 2026. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.02M | 0.01M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.04M | 0.10M | 0.01M | 0.18M | 0.22M | 0.52M | 0.36M | 4.82M | 0.83M | 0.83M | 0.69M | 0.92M | 1.01M | |||||
| Operating items | |||||||||||||||||||||||||
| Research & DevelopmentR&D | 0.99M | 1.29M | 1.88M | 2.62M | 3.04M | 2.69M | 2.59M | 2.97M | 3.34M | 3.36M | 1.76M | 3.08M | 1.23M | 3.64M | 2.22M | 2.57M | 3.16M | 5.48M | 5.11M | 3.69M | |||||
| Selling, General & AdministrativeSG&A | 1.37M | 1.70M | 1.60M | 2.09M | 1.91M | 2.81M | 2.30M | 2.16M | 1.97M | 0.73M | 1.53M | 2.03M | 0.94M | 1.45M | 0.95M | 1.66M | 1.40M | 1.76M | 2.22M | 2.54M | |||||
| Other Operating ExpensesOther Opex | 8.79M | -0.12M | 0.22M | ||||||||||||||||||||||
| Operating ExpensesOpex | 2.36M | 2.99M | 3.48M | 4.71M | 4.95M | 5.50M | 4.89M | 5.12M | 5.31M | 4.10M | 3.29M | 5.11M | 2.17M | 5.09M | 3.17M | 4.22M | 4.56M | 16.03M | 17.76M | 6.79M | |||||
| Operating IncomeOp. Inc | -2.36M | -2.99M | -3.48M | -4.71M | -4.95M | -5.50M | -4.89M | -5.12M | -5.31M | -4.10M | -3.29M | -5.11M | -2.17M | -5.09M | -3.17M | -4.22M | -4.56M | -16.03M | -17.76M | -6.79M | |||||
| EBIT | -2.36M | -2.99M | -3.48M | -4.71M | -4.95M | -5.50M | -4.89M | -5.12M | -5.31M | -4.10M | -3.29M | -5.11M | -2.17M | -5.09M | -3.17M | -4.22M | -4.56M | -16.03M | -17.76M | -6.79M | |||||
| Non-operating items | |||||||||||||||||||||||||
| Non Operating Interest Expenses | 333.00 | 0.01M | 0.01M | 0.02M | 0.02M | 0.01M | 0.00M | 0.01M | 0.00M | 114.00 | 0.01M | 542.00 | |||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 141.00 | 510.00 | 442.00 | 0.00M | 0.01M | 0.01M | 0.00M | 246.00 | 131.00 | 137.00 | 168.00 | 178.00 | 179.00 | 159.00 | 146.00 | 148.00 | 147.00 | 0.08M | 0.09M | 0.05M | |||||
| Other Non Operating IncomeOther Non Op Inc. | -0.06M | -0.07M | -0.16M | 0.23M | -0.03M | -0.05M | -0.03M | -0.01M | -0.02M | -0.04M | |||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.03M | 0.19M | 0.01M | 0.04M | 0.66M | 0.36M | 0.07M | 0.78M | 0.01M | 0.01M | -0.04M | -0.08M | -0.16M | -0.82M | -8.91M | -0.06M | -0.29M | 2.81M | 0.20M | 0.04M | |||||
| Net income details | |||||||||||||||||||||||||
| EBT | -2.36M | -2.99M | -3.48M | -4.71M | -4.94M | -5.49M | -4.90M | -5.13M | -5.33M | -4.11M | -3.30M | -5.12M | -2.18M | -5.09M | -12.09M | -4.28M | -4.57M | -15.95M | -17.55M | -6.75M | |||||
| Profit After TaxPAT | -2.33M | -2.80M | -3.47M | -4.67M | -4.29M | -5.13M | -4.82M | -4.34M | -5.30M | -4.09M | -3.33M | -5.19M | -2.32M | -5.95M | -12.09M | -4.28M | -4.86M | -15.05M | -17.79M | -6.87M | |||||
| Income from Continuing OperationsIncome (Continuing) | -2.36M | -2.99M | -3.48M | -4.71M | -4.94M | -5.49M | -4.90M | -5.13M | -5.33M | -4.11M | -3.30M | -5.12M | -2.18M | -5.09M | -12.09M | -4.28M | -4.57M | -15.95M | -17.55M | -6.75M | |||||
| Consolidated Net IncomeConsol Net Inc. | -2.36M | -2.99M | -3.48M | -4.71M | -4.94M | -5.49M | -4.90M | -5.13M | -5.33M | -4.11M | -3.30M | -5.12M | -2.18M | -5.09M | -12.09M | -4.28M | -4.57M | -15.95M | -17.55M | -6.75M | |||||
| Income towards Parent CompanyParent Net Inc | -2.36M | -2.99M | -3.48M | -4.71M | -4.94M | -5.49M | -4.90M | -5.13M | -5.33M | -4.11M | -3.30M | -5.12M | -2.18M | -5.09M | -12.09M | -4.28M | -4.57M | -15.95M | -17.55M | -6.75M | |||||
| Preferred Dividend PaymentsPref Dividends | 1.73M | 0.12M | |||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -2.36M | -2.99M | -3.48M | -4.71M | -4.94M | -5.49M | -4.90M | -5.13M | -5.33M | -4.11M | -3.33M | -5.19M | -2.32M | -5.95M | -12.09M | -4.28M | -4.86M | -15.05M | -19.51M | -6.87M | |||||
| Additional items | |||||||||||||||||||||||||
| EPS (Basic) | -135.15 | -233.90 | -176.85 | -239.36 | -251.49 | -279.02 | -224.43 | -128.32 | -55.69 | -758.63 | -21.35 | -24.30 | -5.22 | -16.70 | -2.51 | -5.13 | -5.82 | -21.83 | -21.28 | -7.17 | |||||
| EPS (Diluted) | -135.15 | -233.90 | -176.85 | -239.36 | -251.49 | -279.02 | -224.43 | -128.32 | -55.69 | -758.63 | -21.35 | -24.30 | -8.55 | -16.70 | -2.51 | -5.13 | -5.82 | -21.83 | -21.28 | -7.17 | |||||
| Shares Outstanding | 0.02M | 0.01M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.04M | 0.10M | 0.01M | 0.16M | 0.21M | 0.44M | 0.36M | 4.82M | 0.83M | 0.83M | 0.69M | 0.92M | 0.96M | |||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.02M | 0.01M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.04M | 0.10M | 0.01M | 0.16M | 0.21M | 0.27M | 0.36M | 4.82M | 0.83M | 0.83M | 0.69M | 0.92M | 0.96M | |||||
| EBITDA | -2.36M | -2.99M | -3.48M | -4.71M | -4.95M | -5.50M | -4.89M | -5.12M | -5.31M | -4.10M | -3.29M | -5.11M | -2.17M | -5.09M | -3.17M | -4.22M | -4.56M | -16.03M | -17.76M | -6.79M | |||||
| Interest ExpensesInt Expense | 333.00 | 0.01M | 0.01M | 0.02M | 0.02M | 0.01M | 0.00M | 0.01M | 0.00M | 114.00 | 0.01M | 542.00 |